- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
Alpha-MSH Fragment · Educational Resource
Understanding KPV and Anti-Inflammatory Research
Lysine-Proline-Valine Tripeptide
(Alpha-MSH C-Terminal Fragment)
Investigational Application
Anti-inflammatory, pigmentation research
Administration Protocol
Topical or subcutaneous (subQ), per study protocol
Want to learn more?
A licensed team will reach out to guide you through the research.
Book a consultation →Alpha-MSH Fragment · Educational Resource
Understanding KPV and Anti-Inflammatory Research
01 — Overview
What is KPV?
KPV is a synthetic tripeptide corresponding to the C-terminal sequence of alpha-melanocyte-stimulating hormone (alpha-MSH), studied for its anti-inflammatory properties independent of its parent hormone's pigmentation effects.
As an investigational compound, KPV has not received regulatory approval for therapeutic use in the Philippines or elsewhere. It should be understood strictly as a research compound.
Within research literature, KPV is most frequently studied for its relationship to anti-inflammatory pathways, including gut and skin inflammation models, areas summarized further below.
02 — How it works
How It Works: Melanocortin Receptor Signaling and Anti-Inflammatory Modulation
As a fragment of alpha-MSH, KPV is studied for its ability to modulate melanocortin receptor signaling and inflammatory cytokine production, without replicating the pigmentation effects associated with the full alpha-MSH molecule.
Literature describes KPV's studied interaction with the NF-kB inflammatory signaling pathway as a key mechanism researchers associate with its anti-inflammatory research profile.
Administration in Research
In research literature, KPV is evaluated via both topical application and subcutaneous injection, depending on the study design. As an investigational compound, research contexts differ from any at-home or self-directed use.
03 — Areas of research
Summary of Investigated Research Areas
Preclinical literature evaluates KPV across several key physiological parameters to map its biological interactions:
Melanocortin Receptor Signaling Pathways
Research literature evaluates how KPV, a C-terminal fragment of alpha-MSH, is studied for its relationship to melanocortin receptor activity, independent of pigmentation effects.
Anti-Inflammatory Cytokine Studies
Preclinical studies observe inflammatory cytokine changes following KPV exposure in research models.
Gut Barrier Research
Investigational literature examines KPV's studied relationship to intestinal barrier function and gut inflammation models.
Skin Inflammation Parameters
Some literature investigates KPV's studied topical application in models of skin inflammation.
NF-kB Pathway Studies
Studies explore KPV's studied interaction with the NF-kB inflammatory signaling pathway.
Pharmacokinetic Profiling
Studies characterize the absorption and stability profile of KPV in preclinical research.
04 — FAQ
Frequently Asked Questions
05 — References
References and Academic Literature
Kannengiesser, K., et al. (2011). Melanocortin-Derived Tripeptide KPV Has Anti-Inflammatory Potential in Murine Models of Inflammatory Bowel Disease. Inflammatory Bowel Diseases.
Rajora, N., et al. (1997). Alpha-MSH Production, Receptors, and Influence on Neopterin in a Human Monocyte/Macrophage Cell Line. Journal of Leukocyte Biology.
Dalmasso, G., et al. (2008). PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation. Gastroenterology.
i
Medical Education Disclaimer: This page is intended strictly for educational and informational purposes regarding the scientific history and development of chemical compounds. It does not constitute medical advice, promotion, or advertising of any prescription medication. Any therapeutic applications must be evaluated and managed exclusively by a licensed medical practitioner.
Getting started
How to Get Started?
1. Consult
Book a free consultation with our licensed healthcare team.
100 % online. Hassle-free. Convenient.
2. Real Human Assessment
Talk with Philippine-licensed doctors and get prescribed.
Always doctor-led—never just an online form.
Free consultation with licensed providers
3. Start your Program
Your medication is prepared and delivered to your doorstep.
No lock-ins. No hidden fees. No subscriptions.
Formulated in FDA-regulated pharmacies
4. Consistent care
Stay on track with regular weekly follow-ups. On your chosen communication platform.
Unlimited complementary follow-ups
